Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-019215

Director sold 8,600 shares at $6.32 ($54,352)

From the SEC's structured data for this filing

Trades in this filing

McKee Amy E · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-24 Sale : show line 1 in the form −8,600 $6.32 $54,352 27,831 D
Open-market sales · 8,600 sh · avg $6.32 · $54,352
Loading xslF345X05/form4.xml…